表紙
市場調查報告書

動物用疫苗的全球市場:2020年∼2028年

Global Veterinary Vaccines Market Forecast 2020-2028

出版商 Inkwood Research 商品編碼 926299
出版日期 內容資訊 英文 234 Pages
商品交期: 2-3個工作天內
價格
動物用疫苗的全球市場:2020年∼2028年 Global Veterinary Vaccines Market Forecast 2020-2028
出版日期: 2020年02月21日內容資訊: 英文 234 Pages
簡介

本報告提供全球動物用疫苗市場調查,市場概要,各種類、技術、疾病類型、地區的市場規模的變化與預測,市場成長要素及阻礙因素分析,市場機會,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 調查範圍和調查手法

  • 調查目的
  • 調查範圍
  • 調查手法
  • 假設與限制

第2章 摘要整理

  • 市場規模與估計
  • 市場概況

第3章 市場動態

  • 市場定義
  • 成長要素
    • 疫苗產品的進步
    • 政府的積極推動的增加
    • 人獸共通感染疾病的增加
    • 寵物飼養者的增加
    • 家畜疾病的增加
  • 阻礙因素
    • 疫苗接種的成本高
    • 動物用疫苗相關對人及動物的副作用
    • 熟練的畜產農戶及獸醫的不足

第4章 市場分析

  • 波特的五力分析
    • 買方議價能力
    • 供給企業談判力
    • 新加入業者的威脅
    • 替代品的威脅
    • 競爭企業間的敵對關係
  • 價值鏈分析
  • 法律規範
  • 市場機會的矩陣
  • 業者情勢

第5章 全球動物用疫苗市場:各類型

  • 家畜用疫苗
    • 豬隻用疫苗
    • 牛用疫苗
    • 家禽用疫苗
    • 水產動物用疫苗
    • 其他
  • 寵物用疫苗
    • 狗用疫苗
    • 貓用疫苗
    • 馬用疫苗

第6章 全球動物用疫苗市場:各技術

  • 弱毒化活病毒疫苗
  • 不活化疫苗
  • 重組疫苗
  • 類毒素疫苗
  • 其他

第7章 全球動物用疫苗市場:各疾病類型

  • 狗的疾病
  • 豬隻的疾病
  • 牛的疾病
  • 家禽的疾病
  • 水產動物的疾病
  • 其他

第8章 全球動物用疫苗市場:各地區

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 比利時
    • 波蘭
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲、紐西蘭
    • 韓國
    • 泰國
    • 印尼
    • 越南
    • 亞太地區
  • 其他地區
    • 南美
    • 中東、非洲

第9章 企業簡介

  • ANICON LABOR GMBH
  • BOEHRINGER INGELHEIM ANIMAL HEALTH GMBH
  • CEVA SANTE ANIMALE
  • ELANCO
  • HESTER BIOSCIENCES LIMITED
  • HIPRA
  • HYGIEIA BIOLOGICAL LABORATORIES
  • MERCK & CO.
  • PHIBRO ANIMAL HEALTH CORP.
  • ROMVAC COMPANY S.A.
  • VAXXINOVA GMBH-GERMANY
  • VIRBAC SA
  • ZOETIS ANIMAL HEALTHCARE
目錄
Product Code: 29693

KEY FINDINGS:

The global veterinary vaccines market is estimated to record a CAGR of 5.88% during the forecast period of 2020-2028. The major factors that fuel the growth of the global market are an increase in the animal population in the developing countries, a surge in demand for animal-based foods, growing incidences of livestock diseases, and a rise in the adoption of a companion animal.

MARKET INSIGHTS:

Vaccines stimulate the immune system with the help of non-pathogenic organisms or by their immunogenic components to develop naturally acquired immunity. Animal vaccines are important for the welfare of the animals and reduce the financial loss of their owners. Animal vaccines are eco-friendly products that help to reduce the use of antibiotics and the risk of drug-resistant microorganisms. The growth of the animal vaccines market is attributed to emerging diseases affecting livestock and companion animal. Crucial issues associated with livestock production systems are productivity losses, uncertain food security, loss of income, and negative impact on human health. The factors restraining the market growth are high costs of vaccinations, side effects associated with veterinary vaccines on human and animal health, and lack of skilled veterinarians and the farmworkers. The lack of veterinarians, together with a shortage of farmworkers skilled enough to administer vaccines, acts as a key restraint for the market growth.

REGIONAL INSIGHTS:

The global market of veterinary vaccines is analyzed geographically on the basis of markets situated across the regions of North America, Europe, Asia Pacific, and the Rest of the World. As of 2019, the market region of North America holds the largest market share with respect to revenue, and the trend continues by the end of the projected period, which is attributed to constant advancement in vaccine technology. The region of Asia Pacific is expected to register the highest growth during the forecast period owing to the increase in pet adoption, a wide variety of product launches, expansion of prominent players in the region, and investments in vaccine manufacturing facilities.

COMPETITIVE INSIGHTS:

Hester Biosciences Ltd, Anicon Labor GmbH, HIPRA, Elanco, Romvac Company S.A., etc. are some of the key players operating and establishing their presence worldwide.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARIES

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. MARKET DEFINITION
  • 3.2. KEY DRIVERS
    • 3.2.1. PROGRESSION IN THE VACCINE PRODUCTS
    • 3.2.2. INCREASING GOVERNMENT INITIATIVES
    • 3.2.3. INCREASING INCIDENCE OF ZOONOTIC DISEASES
    • 3.2.4. SURGE IN THE COMPANION ANIMAL OWNERSHIP
    • 3.2.5. GROWING PREVALENCE OF LIVESTOCK DISEASES
  • 3.3. KEY RESTRAINTS
    • 3.3.1. HIGH COST OF VACCINATIONS
    • 3.3.2. SIDE EFFECTS ASSOCIATED WITH VETERINARY VACCINES ON HUMAN AND ANIMAL HEALTH
    • 3.3.3. LACK OF SKILLED FARMWORKERS AND VETERINARIANS

4. KEY ANALYTICS

  • 4.1. PORTER'S FIVE FORCE ANALYSIS
    • 4.1.1. THREAT OF NEW ENTRY
    • 4.1.2. THREAT OF SUBSTITUTION
    • 4.1.3. BUYER'S POWER
    • 4.1.4. SUPPLIER'S POWER
    • 4.1.5. COMPETITIVE RIVALRY
  • 4.2. VALUE CHAIN ANALYSIS
  • 4.3. REGULATORY FRAMEWORK
  • 4.4. OPPORTUNITY MATRIX
  • 4.5. VENDOR LANDSCAPE

5. MARKET BY VACCINE TYPE

  • 5.1. LIVESTOCK VACCINE
    • 5.1.1. PORCINE VACCINE
    • 5.1.2. BOVINE VACCINE
    • 5.1.3. POULTRY VACCINE
    • 5.1.4. AQUACULTURE VACCINE
    • 5.1.5. OTHER LIVESTOCK VACCINE
  • 5.2. COMPANION VACCINE
    • 5.2.1. CANINE VACCINE
    • 5.2.2. FELINE VACCINE
    • 5.2.3. EQUINE VACCINE

6. MARKET BY TECHNOLOGY

  • 6.1. LIVE ATTENUATED VACCINE
  • 6.2. INACTIVATED VACCINE
  • 6.3. RECOMBINANT VACCINE
  • 6.4. TOXOID VACCINE
  • 6.5. OTHER TECHNOLOGY

7. MARKET BY DISEASE TYPE

  • 7.1. CANINE DISEASE
  • 7.2. PORCINE DISEASE
  • 7.3. BOVINE DISEASE
  • 7.4. POULTRY DISEASE
  • 7.5. AQUACULTURE DISEASE
  • 7.6. OTHER DISEASE TYPE

8. GEOGRAPHICAL ANALYSIS

  • 8.1. NORTH AMERICA
    • 8.1.1. THE UNITED STATES
    • 8.1.2. CANADA
  • 8.2. EUROPE
    • 8.2.1. THE UNITED KINGDOM
    • 8.2.2. FRANCE
    • 8.2.3. GERMANY
    • 8.2.4. ITALY
    • 8.2.5. RUSSIA
    • 8.2.6. BELGIUM
    • 8.2.7. POLAND
    • 8.2.8. REST OF EUROPE
  • 8.3. ASIA PACIFIC
    • 8.3.1. CHINA
    • 8.3.2. JAPAN
    • 8.3.3. INDIA
    • 8.3.4. AUSTRALIA & NEW ZEALAND
    • 8.3.5. SOUTH KOREA
    • 8.3.6. THAILAND
    • 8.3.7. INDONESIA
    • 8.3.8. VIETNAM
    • 8.3.9. REST OF ASIA PACIFIC
  • 8.4. REST OF WORLD
    • 8.4.1. LATIN AMERICA
    • 8.4.2. MIDDLE EAST & AFRICA

9. COMPANY PROFILES

  • 9.1. ANICON LABOR GMBH
  • 9.2. BOEHRINGER INGELHEIM ANIMAL HEALTH GMBH
  • 9.3. CEVA SANTE ANIMALE
  • 9.4. ELANCO (ELI LILLY AND COMPANY)
  • 9.5. HESTER BIOSCIENCES LIMITED
  • 9.6. HIPRA
  • 9.7. HYGIEIA BIOLOGICAL LABORATORIES
  • 9.8. MERCK & CO.
  • 9.9. PHIBRO ANIMAL HEALTH CORP.
  • 9.10. ROMVAC COMPANY S.A.
  • 9.11. VAXXINOVA GMBH-GERMANY
  • 9.12. VIRBAC SA
  • 9.13. ZOETIS ANIMAL HEALTHCARE

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - VETERINARY VACCINE
  • TABLE 2: GLOBAL VETERINARY VACCINES, BY VACCINE TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 3: GLOBAL VETERINARY VACCINES, BY VACCINE TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 4: GLOBAL LIVESTOCK VACCINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 5: GLOBAL LIVESTOCK VACCINE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 6: GLOBAL LIVESTOCK VACCINE MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 7: GLOBAL LIVESTOCK VACCINE MARKET, BY TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 8: GLOBAL PORCINE VACCINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 9: COMMERCIALLY AVAILABLE PORCINE VACCINES
  • TABLE 10: GLOBAL PORCINE VACCINE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 11: GLOBAL BOVINE VACCINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 12: COMMERCIALLY AVAILABLE BOVINE VACCINES
  • TABLE 13: GLOBAL BOVINE VACCINE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 14: GLOBAL POULTRY VACCINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 15: COMMERCIALLY AVAILABLE POULTRY VACCINES
  • TABLE 16: GLOBAL POULTRY VACCINE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 17: GLOBAL AQUACULTURE VACCINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 18: COMMERCIALLY AVAILABLE AQUACULTURE VACCINES
  • TABLE 19: GLOBAL AQUACULTURE VACCINE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 20: GLOBAL OTHER LIVESTOCK VACCINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 21: GLOBAL OTHER LIVESTOCK VACCINE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 22: GLOBAL COMPANION VACCINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 23: GLOBAL COMPANION VACCINE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 24: GLOBAL COMPANION VACCINE MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 25: GLOBAL COMPANION VACCINE MARKET, BY TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 26: GLOBAL CANINE VACCINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 27: COMMERCIALLY AVAILABLE CANINE VACCINES
  • TABLE 28: GLOBAL CANINE VACCINE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 29: GLOBAL FELINE VACCINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 30: COMMERCIALLY AVAILABLE FELINE VACCINES
  • TABLE 31: GLOBAL FELINE VACCINE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 32: GLOBAL EQUINE VACCINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 33: COMMERCIALLY AVAILABLE EQUINE VACCINES
  • TABLE 34: GLOBAL EQUINE VACCINE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 35: GLOBAL VETERINARY VACCINES, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 36: GLOBAL VETERINARY VACCINES, BY TECHNOLOGY, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 37: GLOBAL LIVE ATTENUATED VACCINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 38: GLOBAL LIVE ATTENUATED VACCINE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 39: GLOBAL INACTIVATED VACCINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 40: GLOBAL INACTIVATED VACCINE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 41: GLOBAL RECOMBINANT VACCINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 42: GLOBAL RECOMBINANT VACCINE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 43: GLOBAL TOXOID VACCINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 44: GLOBAL TOXOID VACCINE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 45: GLOBAL OTHER TECHNOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 46: GLOBAL OTHER TECHNOLOGY MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 47: GLOBAL VETERINARY VACCINES, BY DISEASE TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 48: GLOBAL VETERINARY VACCINES, BY DISEASE TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 49: GLOBAL CANINE DISEASE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 50: GLOBAL CANINE DISEASE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 51: GLOBAL PORCINE DISEASE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 52: GLOBAL PORCINE DISEASE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 53: GLOBAL BOVINE DISEASE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 54: GLOBAL BOVINE DISEASE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 55: GLOBAL POULTRY DISEASE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 56: GLOBAL POULTRY DISEASE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 57: GLOBAL AQUACULTURE DISEASE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 58: GLOBAL AQUACULTURE DISEASE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 59: GLOBAL OTHER DISEASE TYPE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 60: GLOBAL OTHER DISEASE TYPE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 61: GLOBAL VETERINARY VACCINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 62: GLOBAL VETERINARY VACCINE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 63: NORTH AMERICA VETERINARY VACCINE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 64: NORTH AMERICA VETERINARY VACCINE MARKET, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 65: EUROPE VETERINARY VACCINE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 66: EUROPE VETERINARY VACCINE, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 67: ASIA PACIFIC VETERINARY VACCINE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 68: ASIA PACIFIC VETERINARY VACCINE MARKET, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 69: REST OF WORLD VETERINARY VACCINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 70: REST OF WORLD VETERINARY VACCINE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

LIST OF FIGURES

  • FIGURE 1: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 2: OPPORTUNITY MATRIX
  • FIGURE 3: VENDOR LANDSCAPE
  • FIGURE 4: GLOBAL VETERINARY VACCINES, BY VACCINE TYPE, IN 2019
  • FIGURE 5: GLOBAL VETERINARY VACCINES MARKET, BY LIVESTOCK VACCINE, 2020-2028 (IN $ MILLION)
  • FIGURE 6: GLOBAL LIVESTOCK VACCINE MARKET, BY PORCINE VACCINE, 2020-2028 (IN $ MILLION)
  • FIGURE 7: GLOBAL LIVESTOCK VACCINE MARKET, BY BOVINE VACCINE, 2020-2028 (IN $ MILLION)
  • FIGURE 8: GLOBAL LIVESTOCK VACCINE MARKET, BY POULTRY VACCINE, 2020-2028 (IN $ MILLION)
  • FIGURE 9: GLOBAL LIVESTOCK VACCINE MARKET, BY AQUACULTURE VACCINE, 2020-2028 (IN $ MILLION)
  • FIGURE 10: GLOBAL LIVESTOCK VACCINE MARKET, BY OTHER LIVESTOCK VACCINE, 2020-2028 (IN $ MILLION)
  • FIGURE 11: GLOBAL VETERINARY VACCINES MARKET, BY COMPANION VACCINE, 2020-2028 (IN $ MILLION)
  • FIGURE 12: GLOBAL COMPANION VACCINE MARKET, BY CANINE VACCINE, 2020-2028 (IN $ MILLION)
  • FIGURE 13: GLOBAL COMPANION VACCINE MARKET, BY FELINE VACCINE, 2020-2028 (IN $ MILLION)
  • FIGURE 14: GLOBAL COMPANION VACCINE MARKET, BY EQUINE VACCINE, 2020-2028 (IN $ MILLION)
  • FIGURE 15: GLOBAL VETERINARY VACCINES, BY TECHNOLOGY, IN 2019
  • FIGURE 16: GLOBAL VETERINARY VACCINES MARKET, BY LIVE ATTENUATED VACCINE, 2020-2028 (IN $ MILLION)
  • FIGURE 17: GLOBAL VETERINARY VACCINES MARKET, BY INACTIVATED VACCINE, 2020-2028 (IN $ MILLION)
  • FIGURE 18: GLOBAL VETERINARY VACCINES MARKET, BY RECOMBINANT VACCINE, 2020-2028 (IN $ MILLION)
  • FIGURE 19: GLOBAL VETERINARY VACCINES MARKET, BY TOXOID VACCINE, 2020-2028 (IN $ MILLION)
  • FIGURE 20: GLOBAL VETERINARY VACCINES MARKET, BY OTHER TECHNOLOGY, 2020-2028 (IN $ MILLION)
  • FIGURE 21: GLOBAL VETERINARY VACCINES, BY DISEASE TYPE, IN 2019
  • FIGURE 22: GLOBAL VETERINARY VACCINES MARKET, BY CANINE DISEASE, 2020-2028 (IN $ MILLION)
  • FIGURE 23: GLOBAL VETERINARY VACCINES MARKET, BY PORCINE DISEASE, 2020-2028 (IN $ MILLION)
  • FIGURE 24: GLOBAL VETERINARY VACCINES MARKET, BY BOVINE DISEASE, 2020-2028 (IN $ MILLION)
  • FIGURE 25: GLOBAL VETERINARY VACCINES MARKET, BY POULTRY DISEASE, 2020-2028 (IN $ MILLION)
  • FIGURE 26: GLOBAL VETERINARY VACCINES MARKET, BY AQUACULTURE DISEASE, 2020-2028 (IN $ MILLION)
  • FIGURE 27: GLOBAL VETERINARY VACCINES MARKET, BY OTHER DISEASE TYPE, 2020-2028 (IN $ MILLION)
  • FIGURE 28: NORTH AMERICA VETERINARY VACCINE MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 29: THE UNITED STATES VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 30: CANADA VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 31: EUROPE VETERINARY VACCINE MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 32: THE UNITED KINGDOM VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 33: FRANCE VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 34: GERMANY VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 35: ITALY VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 36: RUSSIA VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 37: BELGIUM VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 38: POLAND VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 39: REST OF EUROPE VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 40: ASIA PACIFIC VETERINARY VACCINE MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 41: CHINA VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 42: JAPAN VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 43: INDIA VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 44: AUSTRALIA & NEW ZEALAND VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 45: SOUTH KOREA VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 46: THAILAND VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 47: INDONESIA VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 48: VIETNAM VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 49: REST OF ASIA PACIFIC VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 50: REST OF WORLD VETERINARY VACCINE MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 51: LATIN AMERICA VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 52: MIDDLE EAST & AFRICA VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)